Inhibikase Therapeutics, Inc. (IKT) Market Cap

Inhibikase Therapeutics, Inc. (IKT) has a market capitalization of $145.6M, based on the latest available market data.

Financials updated after earnings reported 2025-09-30.

Sector: Healthcare
Industry: Biotechnology
Employees: 15
Exchange: NASDAQ Capital Market
Headquarters: Atlanta, GA, US
Website: https://www.inhibikase.com

Loading company profile...

SEC Filings